Minimal Residual Disease (MRD) Testing in Newly Diagnosed Multiple myeloma (MM) Patients: A Prospective Head-to-Head Assessment of Cell-Based, Molecular, and Molecular-Imaging Modalities
Year: 2014
Type: article
Source: Blood
Authors: Neha Korde, Sham Mailankody, Mark Roschewski, Malek Faham, Chitra Kotwaliwale, Martin Moorhead, Mary L Kwok, Elisabet E. Manasanch, Manisha Bhutani, Nishant Tageja, Dickran Kazandjian, Rene Costello, Yong Zhang, Adriana Zingone, Debbie Burton, Marcia Mulquin, Ashley Carpenter, Diamond Zuchlinski, Elizabeth Lamping, George Carter, Candis Morrison, Karen Kurdziel, Maria Lindenberg, Roger Kurlander, Irina Maric, Katherine R. Calvo, Raul C Braylan, Constance Yuan, Maryalice Stetler-Stevenson, Diane C Arthur, Seth M. Steinberg, William D Figg, Peter Choyke, Ola Landgren
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W49164147